The full form of SRL in Medical is Sirolimus. This is a very critical medicine during organ transplants. Sirolimus prevents cases of organ transplant rejection. As per the information available, Sirolimus is also used for treating lymphangioleiomyomatosis, a rare lung condition. Sirolimus is known to be an immunosuppressant, and hence it reduces the functionality of the body’s immune system. This improves the chances of graft success, and it prevents the body’s immune system from attacking the transplanted organ.
Sirolimus is produced by the bacterium Streptomyces hygroscopicus, and the bacteria was first isolated in 1972. In 1999, Sirolimus was approved by the FDA for use. Sirolimus is not toxic towards kidneys; hence, it has been found to have higher adaptability in the medical domain. It is especially beneficial to patients with kidney failure because of the hemolytic uremic syndrome. The medicine is available in the form of oral solutions and the form of tablets.
Other full forms of SRL